onitoring drug fficacy through ulti-mics esearch initiative in lzheimer’s isease (MEMORI-AD): A protocol for a multisite exploratory prospective cohort study on the drug response-related clinical, genetic, microbial and metabolomic signatures in Filipino patients with Alzheimer’s diseaseFresthel Monica M Climacosa, Veeda Michelle M Anlacan, Francis James A Gordovez, John Carlo B. Reyes, Ian Kim B Tabios, Rafael Vincent M Manalo, Joana Marie Ceripulo Cruz, Joannes Luke B Asis, Rozel B Razal, Mark Joseph M Abaca, Aira B Dacasin, Ayra Patrice N Espiritu, Nicole Clarence Louise L Gapaz, Melody Hope L Lee Yu
27 November 2024
MuSic Moves—co-creating a music-supported exercise programme with and for people with multiple sclerosis: a bicentre participatory mixed methods studyBernhard Fasching, Sarah Mildner, Franziska Fink, Andreas Wanitschek, Isabella Hotz, Nadine Langweil, Tobias Monschein, Thomas Berger, Christian Brenneis, Fritz Leutmezer, Barbara Seebacher
24 November 2024
Efficacy and safety of hyperbaric oxygen therapy for Parkinson’s disease with cognitive dysfunction: protocol for a systematic review and meta-analysisWeiqiang Tan, Zhaoquan Pan, Fengxi Xie
20 November 2024
‘Blue-lighting’ seizure-related needs in care homes: a retrospective analysis of ambulance call-outs for seizures in North West England (2014–2021), their management and costs, with community comparisonsAdam J Noble, Steven Lane, Peter Lloyd, Beth Morris, Steve Bell, Tom Shillito, Pete Dixon, Anthony Guy Marson
13 November 2024
Intra-arterial alteplase for acute ischaemic stroke after mechanical thrombectomy (PEARL): rationale and design of a multicentre, prospective, open-label, blinded-endpoint, randomised controlled trialXinguang Yang, Xiongjun He, Dong Pan, Yongteng Xu, Huiyuan Peng, Kaifeng Li, Min Zhang, Yingying Zhu, Yanting Chen, Baixuan He, Hongxing Zhou, Jie Li, Hongbiao Hou, Haoyang Sun, Yajie LiuSee the full list of authors
5 November 2024
Primary headache content on online community platforms: a scoping review protocolKendall Chaffin, Anna Horvath, Sophie Ahmad, Rooman Ahad, Kavita Batra
1 November 2024
Living systematic review and comprehensive network meta-analysis of ALS clinical trials: study protocolFloris T Van Loon, Georgios Seitidis, Dimitris Mavridis, Jordi W J van Unnik, Daphne N Weemering, Leonard H van den Berg, Ilianna Bethani, Stavros Nikolakopoulos, Ruben P A van Eijk
1 November 2024
Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) studyKeiko Imamura, Yuishin Izumi, Naohiro Egawa, Takashi Ayaki, Makiko Nagai, Kazutoshi Nishiyama, Yasuhiro Watanabe, Takenobu Murakami, Ritsuko Hanajima, Hiroshi Kataoka, Takao Kiriyama, Hitoki Nanaura, Kazuma Sugie, Takehisa Hirayama, Osamu KanoSee the full list of authors
26 October 2024
VAL-1221 for the treatment of patients with Lafora disease: study protocol for a single-arm, open-label clinical trialLorenzo Muccioli, Luca Vignatelli, Maria Tappatà, Serena Mazzone, Corrado Zenesini, Dustin Armstrong, DEFEAT-LD study group, Roberto Michelucci, Francesca Bisulli, DEFEAT-LD study group, Cosimo Altomare, Massimo Carella, Cinzia Costa, Giuseppe Damante, Lidia Di VitoSee the full list of authors
18 October 2024
Impact of dual sensory impairment on the risk of incident dementia: a protocol for a systematic review and meta-analysisStefano Giannoni-Luza, Daniele Urso, Ahmed Amine Alaoui, Jeremy Ting, Samir Jabbour, Adrian Fuente
17 October 2024
